- Home
- APLT vs DHC Comparison
APLT vs DHC Comparison
Compare APLT & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- DHC
- Stock Information
- Founded
- APLT 2016
- DHC 1998
- Country
- APLT United States
- DHC United States
- Employees
- APLT N/A
- DHC N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- DHC Real Estate Investment Trusts
- Sector
- APLT Health Care
- DHC Real Estate
- Exchange
- APLT Nasdaq
- DHC Nasdaq
- Market Cap
- APLT 971.6M
- DHC 855.2M
- IPO Year
- APLT 2019
- DHC N/A
- Fundamental
- Price
- APLT $8.69
- DHC $2.52
- Analyst Decision
- APLT Strong Buy
- DHC Hold
- Analyst Count
- APLT 5
- DHC 3
- Target Price
- APLT $12.50
- DHC $4.50
- AVG Volume (30 Days)
- APLT 1.8M
- DHC 1.3M
- Earning Date
- APLT 11-07-2024
- DHC 11-04-2024
- Dividend Yield
- APLT N/A
- DHC 1.59%
- EPS Growth
- APLT N/A
- DHC N/A
- EPS
- APLT N/A
- DHC N/A
- Revenue
- APLT N/A
- DHC $1,477,343,000.00
- Revenue This Year
- APLT N/A
- DHC N/A
- Revenue Next Year
- APLT $3,169.03
- DHC $4.18
- P/E Ratio
- APLT N/A
- DHC N/A
- Revenue Growth
- APLT N/A
- DHC 6.62
- 52 Week Low
- APLT $1.79
- DHC $1.97
- 52 Week High
- APLT $10.62
- DHC $4.24
- Technical
- Relative Strength Index (RSI)
- APLT 46.34
- DHC 28.34
- Support Level
- APLT $9.44
- DHC $2.46
- Resistance Level
- APLT $10.62
- DHC $2.79
- Average True Range (ATR)
- APLT 0.62
- DHC 0.21
- MACD
- APLT -0.13
- DHC -0.07
- Stochastic Oscillator
- APLT 14.95
- DHC 4.80
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.